{"DataElement":{"publicId":"6072781","version":"1","preferredName":"Adverse Event MedDRA Low Level Term Version 20 Code","preferredDefinition":"Numeric value to represent any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure (adverse event),using terminology from the Medical Dictionary for Regulatory Affairs (MedDRA) version 20.0.","longName":"AE_MEDDRA_V20_CD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2747697","version":"1","preferredName":"Adverse Event Meddra Low Level Term MedDRA Code","preferredDefinition":"Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).:Lowest level of the terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym._An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology.:A system, often of numbered categories, used for representation of data.","longName":"2747583v1.0:2734836v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2747583","version":"1","preferredName":"Adverse Event Meddra Low Level Term","preferredDefinition":"Any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.  Such events can be intervention related, dose related, route related, patient related, or caused by an interaction with another drug(s) or procedure(s).:Lowest level of the terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym.","longName":"C41331:C71886","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MedDRA Low Level Term","conceptCode":"C71886","definition":"Lowest level of the MedDRA terminology, related to a single PT as a synonym, lexical variant, or quasi-synonym.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96CF4B-38E7-1C4E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"ONEDATA","dateModified":"2008-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2734836","version":"1","preferredName":"MedDRA Code","preferredDefinition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology.:A system, often of numbered categories, used for representation of data.","longName":"C43820:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MedDRA","conceptCode":"C43820","definition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4843080F-4FFA-4D06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-12","endDate":null,"createdBy":"UMLLOADER_C3PR","dateCreated":"2008-03-12","modifiedBy":"ONEDATA","dateModified":"2008-03-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96E7B9-47F9-3AF4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"8/13/12 - CDE already released; caAERS v2.0 model released; caAERS v1.0 retired.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6072780","version":"1","preferredName":"MedDRA Adverse Event Version 20 Adverse Event Code","preferredDefinition":"MedDRA Code to represent any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation._Version; something a little different from others of the same type; one of a sequence of copies of a program, each incorporating new modifications.__A number with no fractional part, including the negative and positive numbers as well as zero.::20_Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"MEDDRA_V20_AE_CD","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6072779","version":"1","preferredName":"MedDRA Version Integer::20 Adverse Event Code","preferredDefinition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.:A number with no fractional part, including the negative and positive numbers as well as zero.::20:Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6072779v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MedDRA","conceptCode":"C43820","definition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Version","conceptCode":"C25714","definition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"655B7852-B113-3753-E053-F662850AEC69","latestVersionIndicator":"Yes","beginDate":"2018-02-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-16","modifiedBy":"ONEDATA","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MedDRA v20.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"655B7852-B124-3753-E053-F662850AEC69","latestVersionIndicator":"Yes","beginDate":"2018-02-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-16","modifiedBy":"MAESKEB","dateModified":"2020-12-17","changeDescription":"Created to support MedDRA codes for CTCAE v5.0.  CTEP confirms these codes are MedDRA 20.1 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"MedDRA Code","type":"Preferred Question Text","description":"MedDRA Code","url":null,"context":"NCIP"}],"origin":"MedDRA v20.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"655B9DEF-9484-454A-E053-F662850A63ED","latestVersionIndicator":"Yes","beginDate":"2018-02-16","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-16","modifiedBy":"MAESKEB","dateModified":"2018-06-14","changeDescription":"Curated to support release of CTCAE v5.0.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}